Osmol Therapeutics
PrivateLast Round
Series A
Extension
Apr 12, 2022
Total Funding Raised
$7.5M
Company Overview
Osmol Therapeutics operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Series A Extension round in April 2022.
Osmol Therapeutics is a biopharmaceutical company developing a first-in-class preventative treatment for chemotherapy-induced peripheral neuropathy and chemotherapy-induced cognitive impairment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Osmol Therapeutics Comparables
Compare Osmol Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaremed AG | 80% | |
| Eli Lilly and Company | 78% | |
| Dogwood Therapeutics, Inc. | 77% |
For institutional investors. Book with your work email.
Osmol Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 12, 2022 | ||||
| Series A | Dec 1, 2016 |
For institutional investors. Book with your work email.
Osmol Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elm Street Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 12, 2022
Raised $8M in a Series A Extension round.
- Dec 1, 2016
Led by Elm Street Ventures
For institutional investors. Book with your work email.
Osmol Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Osmol Therapeutics's valuation, stock price, and market status.
Is Osmol Therapeutics a public or private company?
Osmol Therapeutics is a private company.
What is the current stock price of Osmol Therapeutics?
Osmol Therapeutics is a private company, so its shares have no public market price. Caplight tracks Osmol Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Osmol Therapeutics worth (valuation)?
Valuation information for Osmol Therapeutics is not publicly available.
Can I buy Osmol Therapeutics stock?
Osmol Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Osmol Therapeutics's last funding round?
Osmol Therapeutics's most recent funding round was Series A Extension on April 12, 2022.
Who are the main investors in Osmol Therapeutics?
Key investors in Osmol Therapeutics include Elm Street Ventures.
Will Osmol Therapeutics IPO soon?
No public IPO plans have been announced for Osmol Therapeutics.
How can I track Osmol Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Osmol Therapeutics's shares on secondary markets.